Innospec Stock Performance

IOSP Stock  USD 65.89  -1.34  -1.99%   
The firm maintains a market beta of 1.06, which implies a somewhat significant risk relative to the market. Returns on Innospec closely shadow the overall market, offering near-index exposure without significant amplification or dampening. At this point, Innospec has a negative expected return of -0.26%. Please make sure to verify Innospec's relationship between the rate of daily change and period momentum indicator, to decide if Innospec's performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weak
 
Weak
 
Strong
Innospec has delivered negative risk-adjusted returns across the last 90 days, suggesting that volatility was not compensated by return. Used correctly, this score supports evaluation of raw price movement versus actual return efficiency. Even with weak performance in the last few months, the stock's basic indicators remain relatively invariable, which may send shares a bit higher in April 2026. The latest agitation may also be a sign of long-running up-swing for the company's retail investors. Learn More
Begin Period Cash Flow289.2 M
Total Cashflows From Investing Activities-75.1 M

Relative Risk vs. Return Landscape

If you had invested $ 7,788 in Innospec on December 21, 2025 and sold it today you would have lost $ 1,199 from holding Innospec or given up 15.4% of portfolio value over 90 days. Innospec does not currently generate positive expected returns and carries 1.4985% risk (volatility on return distribution) over a 90-day horizon. In different words, 13% of stocks are less volatile than Innospec, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
This market-relative note looks at return potential and the amount of risk required to get it. It highlights whether the current reward profile compensates for the level of uncertainty assumed. Given the investment horizon of 90 days Innospec is expected to under-perform the market. In addition to that, the company is 1.82 times more volatile than its market benchmark. It trades about -0.18 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.11 per unit of volatility.

Target Price Odds to finish over Current Price

For Innospec Stock, the observed tendency of price to return to a central value is a key input to forecasting models. This mean reversion pattern, however, does not apply uniformly - some stocks remain mispriced for extended periods, suggesting that embedded risk premiums affect the speed of correction.
Current PriceHorizonTarget PriceOdds moving above the current price in 90 days
65.89 90 days 65.89
about 99.0
According to a normal distribution model, the odds of Innospec moving above the current price in 90 days from now are about 99.0 (The density curve for Innospec shows where Innospec Stock price is most likely to settle within 90 days).
Given the investment horizon of 90 days the stock has the beta coefficient of 1.06 . This usually indicates Innospec market returns are sensible to returns on the market. As the market goes up or down, Innospec is expected to follow. Additionally, Innospec has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Innospec Price Density   
       Price  

Predictive Modules for Innospec

A wide range of forecasting techniques can be applied to Innospec and the broader stock market. While market prediction remains inherently uncertain, combining multiple approaches and evaluating their results is one of the most effective ways to improve the quality of investment decisions.
Mean reversion in Innospec is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Hype
Prediction
LowEstimatedHigh
64.2265.7267.22
Details
Intrinsic
Valuation
LowRealHigh
59.3071.4872.98
Details
Naive
Forecast
LowNextHigh
67.3168.8170.30
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
62.9877.7992.61
Details
Effective investment decisions about Innospec require competitive context. Benchmarking Innospec's against peers on earnings quality, growth consistency, and balance sheet strength can materially change the investment conclusion.

Primary Risk Indicators

The stock market's recent history has been defined by volatility, with multiple large corrections and rallies in the last 10-20 years. Innospec has participated in these swings. Investors holding Innospec can protect their portfolios by monitoring Innospec's risk indicators and implementing appropriate hedging strategies.
α
Alpha over Dow Jones
-0.1686
β
Beta against Dow Jones1.06
σ
Overall volatility
5.64
Ir
Information ratio -0.1163

Investor Alerts and Insights

Investors in Innospec benefit from automated alerts that flag material stock changes as they occur. Innospec notifications cover technical signals, fundamental shifts, and notable headlines that may impact investment timing.
Innospec generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Short Interest in Minerals Technologies Inc. Expands By 29.1 percent - Market Beat

Price Density Drivers

Key market indicators for Innospec reflect the tension between long and short positioning, along with broader investor sentiment. Reviewing the table below supports assessment of the current dynamics driving Innospec's price behavior.
Common Stock Shares Outstanding25 M
Cash And Short Term Investments292.5 M

Innospec Fundamentals Growth

The market prices Innospec Stock according to Innospec's ability to generate revenue growth, maintain healthy margins, and manage debt effectively. These fundamental drivers have a direct and measurable impact on Innospec Stock performance.

Performance Metrics & Calculation Methodology

Innospec performance is measured on a risk-adjusted basis against benchmarks. Liquidity conditions can influence realized performance through spreads and execution cost. Innospec shows ROE of 9.15%, ROA of 5.47%.

The analytics block for Innospec relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Return and risk statistics are calculated from historical price series.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 5th, 2026